|Company Name||# of Hedge Funds||# of Insiders Buying||# of Insiders Selling|
|ShangPharma Corp (ADR) (NYSE:SHP)||6||0||0|
|ArQule, Inc. (NASDAQ:ARQL)||13||0||0|
|OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)||4||0||0|
|Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)||10||0||0|
|Durata Therapeutics Inc (NASDAQ:DRTX)||5||7||0|
With the results exhibited by the aforementioned strategies, retail investors should always monitor hedge fund and insider trading activity, and Cytokinetics, Inc. (NASDAQ:CYTK) applies perfectly to this mantra.